GENinCode Plc (LON:GENI – Get Free Report) shares rose 14.3% during mid-day trading on Wednesday . The company traded as high as GBX 4.80 ($0.06) and last traded at GBX 4.80 ($0.06). Approximately 316,261 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 1,354,248 shares. The stock had previously closed at GBX 4.20 ($0.05).
GENinCode Price Performance
The stock has a market capitalization of £8.49 million, a P/E ratio of -96.00 and a beta of 0.66. The company has a debt-to-equity ratio of 9.27, a quick ratio of 15.89 and a current ratio of 2.60. The firm has a 50-day moving average price of GBX 3.85 and a 200 day moving average price of GBX 5.10.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.
Recommended Stories
- Five stocks we like better than GENinCode
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- What Does the Future Hold for Eli Lilly?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
